BBreakthrough Properties creates and manages dedicated life science campuses and facilities to support biotechnology and pharmaceutical research. It acquires, develops, and leases high-quality research spaces, earning revenue from long-term leases with leading biotech firms. The company combines real estate know-how from Tishman Speyer with biotech entrepreneurship from Bellco Capital to operate in the under-supplied life science real estate market, and its flagship 185,000-square-foot campus is fully leased to Turning Point Therapeutics, a Bristol Myers Squibb subsidiary. Its goal is to enable scientific breakthroughs by providing specialized, well-supported environments for R&D, while growing a diversified portfolio of life science properties through strategic development and partnerships.
Work here?Claim your company
We're working on gathering enough insights on this company, check back soon!
Industries
Company Size
51-200
Company Stage
Debt Financing
Total Funding
$41.8M
Headquarters
Los Angeles, CA
Founded
2019
See people who can refer or advise you
Total Funding
$41.8M
Above
Industry Average
Funded Over
1 Rounds
McLaughlin & Harvey sets new standards in life sciences construction. The UK's fast-evolving innovation ecosystem is fuelling demand for flexible, high-spec laboratories and workspaces tailored to both established and emerging science-led businesses, Alan Mackenzie, bid director and sector lead for life sciences & commercial at McLaughlin & Harvey, has said. Since July 2025, the life sciences sector has drawn £3bn in new public-private funding, underscoring continued confidence in the UK's global scientific standing. Within the Golden Triangle of London, Oxford and Cambridge, 3.3m sq ft of life sciences space is currently being built, with a further 6.5m sq ft consented, highlighting the sector's momentum. McLaughlin & Harvey has already delivered more than 550,000 sq ft of laboratories across the Triangle and has a further 950,000 sq ft in the pipeline, working closely with clients and supply chain partners to advance sustainability targets and raise the bar for delivery quality. Since 2023, the company has partnered with Breakthrough Properties on two flagship schemes. At Trinity by Breakthrough in Oxford, the ambition was to create one of the world's most sustainable laboratory environments to attract leading biotech, pharmaceutical and genomics organisations. From the outset, the project team aligned around shared priorities - sustainability, quality and commercial performance - enabling a unified approach and the adoption of alternative solutions where they offered clear benefits. - Advertisement - A bespoke raft foundation with a ventilated basement void, the integration of renewable technologies and rigorous design coordination underpinned the project's outcomes. Trinity achieved WELL Platinum, EPC A and BREEAM Outstanding - placing it among the top 1% of new non-domestic buildings. Reflecting confidence in delivery, McLaughlin & Harvey was also awarded, in competition, a full turnkey fit-out for one Studio Laboratories floor, with completion aligned to the main programme. Building on this success, the contractor is now delivering Vitrum by Breakthrough at St John's Innovation Park in Cambridge - a purpose-built, world-class facility designed to foster collaboration and accelerate discovery across the life sciences. Trinity by Breakthrough's flexibility, sustainability credentials and coordinated execution were recognised with the Best New Building award at the Construction News & Property Week Life Science, Tech & Research Clusters Awards, while Breakthrough Properties has been shortlisted for Client of the Year at the Building Awards. "What is essential is to have a good construction partner. On our Trinity development in Oxford, McLaughlin & Harvey was a phenomenal contractor. And, on that basis, we negotiated our Vitrum development with them and again they have continued to be an exceptional partner". - Thomas Renn, Senior Vice President (Acquisitions & Development, Europe), Breakthrough Properties. McLaughlin & Harvey is also advancing the sector in London at 105 Judd Street, where it is refurbishing and extending a prime office building for Native Land and Ashby Capital to create adaptable lab-enabled and office space. The scheme will be fully let to Life Arc - the UK's largest life sciences letting in 2025 - with specifications allowing straightforward conversion of office floors to laboratories to meet evolving tenant needs. To sustain and broaden sector growth, the company argues the industry must look beyond the Golden Triangle to high-potential locations not yet on the life sciences map. To support this, it has commissioned research resulting in the Alchemy Towns Index, which evaluates 40 UK towns and cities for future development potential. The report aims to catalyse discussion, translate promising pipelines into viable projects and accelerate the delivery of high-quality facilities nationwide. As the market continues to mature, designing and constructing state-of-the-art, adaptable buildings that can flex over their lifespans will be essential to unlocking the UK's growing life sciences opportunity.
Breakthrough Properties buys biomanufacturing campus in Everett, secures lease. * john stearns * 4 hrs ago. Los Angeles-based Breakthrough Properties, a global life-science real estate developer, today announced it has acquired a biomanufacturing facility at 215 Shuksan Way in Everett and secured a separate 21-year lease for the entire campus with an undisclosed global biopharma company to create a U.S. manufacturing facility. Breakthrough, a joint venture of Tishman Speyer and Bellco Capital, bought the 270,000-square-foot property at 215 Shuksan Way for $78 million. It's its first investment in the Puget Sound region, it noted in a news release. The site was designed for fully integrated, end-to-end manufacturing. It offers a full range of capabilities and amenities, from drug manufacturing, quality-control labs, and warehouse and distribution logistics to administrative office spaces and an onsite café, the release said. The site was originally leased to a biotechnology company that had invested approximately $350 million to build out a biomanufacturing facility but never moved in after being acquired in 2023. While not named in the release, Bothell-based Seagen Inc. was building the campus but never occupied it after its $43-billion acquisition by Pfizer Inc. When Pfizer stopped construction in early 2024, it said medicines Seagen intended to produce at the new plant would be manufactured in North Carolina, which was being expanded and had the necessary capacity, the Seattle Times reported at the time. Meanwhile, the Bothell site is one of Pfizer's newest major R&D hubs following its acquisition of Seagen, according to Pfizer's website. Breakthrough Properties said its Everett deal exemplifies its growing focus on investing in U.S. biomanufacturing infrastructure, part of more than $600 billion of recent onshoring commitments made by major pharmaceutical companies to strengthen domestic supply chains, it said. "This transaction is emblematic of Breakthrough's unique value proposition," Breakthrough Properties CEO Dan Belldegrun said in the release. "We identified an opportunity to unlock near-term value from a newly delivered, state-of-the-art facility by leveraging our global relationship network to seamlessly execute multiple agreements that created a positive outcome for all parties involved. We are thrilled about the next chapter for this world-class facility and to support our partners in achieving their strategic business objectives." Breakthrough says it's one of the most active life-science real estate firms with a portfolio that spans 6 million square feet of premier environments in operation and in the development pipeline across the United States and Europe. It listed notable Breakthrough properties as including One Milestone, its recently completed life-science environment anchored by the Roche Genentech Innovation Center at the new Harvard Enterprise Research Campus; Torrey Heights, a 10-acre San Diego life-science campus that serves as the headquarters for Pfizer's oncology division; and One Helix, a state-of-the-art research facility in Amsterdam, which is fully leased to AstraZeneca.
Closed Pfizer biopharma facility in Everett gets a new owner and a mystery tenant. by John Cook on Aug 14, 2026 at 8:46 am A bio-manufacturing facility in Everett, Wash., which was built by Seattle biotech giant Seagen but never opened under its Pfizer ownership, is getting a new lease on life. Breakthrough Properties, a life sciences real estate company, said Friday that it has acquired the 270,000-square-foot facility at 215 Shuksan Way for $78 million and leased the entire campus for 21 years to an unnamed global biopharmaceutical company. Seagen invested approximately $350 million to build out the facility, which was designed for drug manufacturing, quality-control labs, warehousing and distribution. But the company never moved in after drug maker Pfizer acquired Seagen for $43 billion in 2023. "Pfizer regularly evaluates our manufacturing network to ensure capacity is effectively utilized based on projected product demands," the company said in a statement to GeekWire in 2024. "After careful evaluation, we have made the difficult decision to wind down construction of the site." The facility sits about 25 miles north of Seattle along the I-5 corridor and is Breakthrough Properties' first investment in the Puget Sound region. The deal comes as pharmaceutical companies increase investment in U.S. manufacturing capacity. Breakthrough said major drugmakers have announced more than $600 billion in recent commitments to expand domestic production and strengthen supply chains. The Everett facility was part of Seagen's broader manufacturing expansion before the company was acquired by Pfizer for $43 billion. GeekWire previously reported on Seagen's plans for the 270,000-square-foot Everett facility. Breakthrough Properties is a joint venture between global real estate company Tishman Speyer and biotech investment firm Bellco Capital. A spokesperson for the company, which owns and develops life sciences properties in the U.S. and Europe, declined to provide details on the new tenant or the move-in date.
McLaughlin & Harvey and Breakthrough Properties shortlisted for Construction Client of the Year. McLaughlin & Harvey's work with Breakthrough Properties has been shortlisted for the Building Awards 2026 in the Construction Client of the Year category. The nomination acknowledges the partners' joint delivery of innovative life sciences facilities. Construction Client of the Year celebrates clients that demonstrate exemplary delivery, including effective supply chain collaboration, strong sustainability performance, and projects completed on time and within budget. - Advertisement - McLaughlin & Harvey has partnered with Breakthrough Properties on Trinity by Breakthrough in Oxford and Vitrum by Breakthrough in Cambridge. The schemes are cited as setting fresh benchmarks for the sector, showcasing how a bold vision and integrated supply chains can achieve standout outcomes. Alan Mackenzie, Bid Director, McLaughlin & Harvey, said: "It's fantastic to have our partnership with Breakthrough Properties recognised in the shortlist for the Building Awards 2026. The nomination is acknowledgement of the close collaboration required for successful construction projects." Latest construction news. 10/08/2026 Uisce Éireann will begin a major mains replacement later this month to improve water security in the Lough Atalia area of Galway, replacing more than 1.8km of ageing pipes along key routes, with completion expected in early 2027 and traffic measures including night-time lane closures. Customers on 10/08/2026 More than 250 colleagues from Uisce Éireann's North West framework gathered at the Clayton Hotel Sligo for a safety, training and wellbeing Soft Start to mark the return to work. Held on 6 August 2026, the event brought together Farrans, its supply chain partners and client Uisce Éireann to reconne 10/08/2026 Sinn Féin MLA Declan Kearney has welcomed a revamped Road Maintenance Strategy unveiled by party colleague and Infrastructure Minister Liz Kimmins, saying it will transform how roads are maintained and improve journeys for motorists across the north. The South Antrim MLA said: "The new Road Mainten 10/08/2026 McLaughlin & Harvey's work with Breakthrough Properties has been shortlisted for the Building Awards 2026 in the Construction Client of the Year category. The nomination acknowledges the partners' joint delivery of innovative life sciences facilities. Construction Client of the Year celebrates cli 10/08/2026 Rory Hearne said Government policy has fuelled a scarcity of affordable rentals, citing a Simon Communities report that found only 20 of 1,303 properties in June were within HAP limits and none in most study areas. The Social Democrats' housing spokesperson argued that people relying on the Housing 10/08/2026 Works to replace nearly 2km of ageing water mains between Toomans and Keshcarrigan will start this week, aiming to curb leaks and strengthen supplies for Keshcarrigan and the wider Ballinamore area. Uisce Éireann will commence a major upgrade of the local water network, with close to 2km of older m 10/08/2026 Alan Dillon TD, Minister of State at the Department of Enterprise, Tourism and Employment with special responsibility for Employment, Small Business and Retail, has reappointed Mr Bernard Gogarty as Chairperson of the Construction Contracts Adjudication Panel established under the Construction Contr 10/08/2026 A €3.8 million programme to modernise Ballaghaderreen's wastewater treatment plant has begun this month, strengthening performance and resilience while protecting the local environment. Delivered by Uisce Éireann, the scheme will upgrade key assets at the facility to improve day-to-day operations, 10/08/2026 London Stansted has named Farrans as its construction partner for new skylink walkways, a key element of the airport's transformation plan. The links will provide direct pedestrian connections between the main terminal and the existing satellite buildings that accommodate departure and arrival gate 10/08/2026 NI Water has announced an out-of-sewer overflow in Co Down was sparked by flushed wipes and sanitary products, triggering a major clean-up to safeguard the Mournes coastline and nearby shellfish habitats. Specialist wastewater crews were deployed to Dundrum Bay to trace and remove a substantial blo
Harvard, Tishman Speyer and Breakthrough Properties celebrate opening of the Enterprise Research Campus in Allston. June 24, 2026 Boston's most anticipated development in years comes to life with apartments, hotel, iconic David Rubenstein Treehouse, cutting-edge labs, restaurants, shops and community open spaces. Harvard University, Tishman Speyer and Breakthrough Properties were joined on June 23 by Mayor Michelle Wu and a host of university, elected, local community and business leaders to celebrate the completion of the first phase of the Enterprise Research Campus (ERC), a dynamic, nine-acre mixed-use development in Boston's Allston neighborhood. The first phase of the ERC, a development led by Tishman Speyer and Breakthrough in partnership with the Harvard Allston Land Company (HALC), brings together two state-of-the-art laboratory buildings devoted to scientific research and development, hundreds of new apartments, a boutique hotel, a conference center, 40,000 square feet of retail and restaurants, and more than two acres of publicly accessible open space anchored by the new Allstonway. "The Enterprise Research campus is where researchers, entrepreneurs, and creative thinkers will work side by side. Asking ambitious questions, pursuing novel ideas that only seem obvious with hindsight. Building the companies and the industries of tomorrow. And as new discoveries are made, new challenges are identified. The spaces we have built will evolve. Supporting excellence in many forms for many, many years to come," said Harvard President Alan Garber. "It's extremely gratifying to see the ERC come to life," said Tishman Speyer CEO Rob Speyer. "From day one, Harvard has been an amazing partner. Our collaboration has created a place for bold ideas, from the next groundbreaking discovery to world-class hospitality. This is a destination for Harvard, Allston, and visitors from around the world." "With the ERC, we have created a world-leading innovation environment that will complement and accelerate cutting-edge research taking place at Harvard and the surrounding region," said Breakthrough Properties CEO Dan Belldegrun. "With Roche Genetech's innovation center as its anchor, One Milestone will produce dynamic partnerships between academia and industry, paving the way for countless life-changing discoveries." Enterprise Research Campus: A Model Mixed-Use Neighborhood The nine-acre first phase of the Enterprise Research Campus encompasses the following elements: One Milestone, the ERC's premier life science environment anchored by Roche's Innovation Center for Cardiovascular, Renal, and Metabolism (CVRM) discovery. Developed by Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, One Milestone encourages connection and the exchange of ideas through an array of collaboration spaces and amenities, including a Jay Wright-designed fitness center and a double-height conference facility. Designed by architectural firms Henning Larsen and Studio Gang, the interconnected, two-building complex accommodates companies of all sizes - from large-scale users to emerging start-ups based in StudioLabs, Breakthrough's flexible lab component. The David Rubenstein Treehouse, Harvard's first university-wide conference center, which opened in October 2025 and hosts events ranging in size from 20 up to 755 people. The Rubenstein Treehouse incorporates space for visiting scholars, industry partners, and guests to convene, collaborate and foster connections. Designed by Studio Gang, the expressive mass timber structure features a double-height lobby that extends outdoors through two covered porches that can be used year-round. The Atlas, a boutique hotel that opened earlier this year. Designed by Marlon Blackwell Architects with interiors for the lobby, corridors and guestrooms by INC Architecture & Design, The Atlas features 246 rooms and an array of amenities, including two dining concepts by the James Beard-nominated Pearl & Law Hospitality, the team behind Dorchester's Comfort Kitchen. Ama at The Atlas, the hotel's signature restaurant concept, and Foxglove Terrace, a rooftop restaurant and bar, both opened in the spring. Verra, the ERC's 343-apartment community, which opened last year. Verra offers thoughtfully designed studios through two-bedroom apartments with an emphasis on comfort, warmth and hospitality. Verra features sweeping views of Boston and Cambridge alongside a curated collection of best-in-class amenities. Designed by MVRDV, Verra is already helping shape the neighborhood's energy and sense of community. An array of street-level shops, restaurants and cafes. Tishman Speyer's retail program has prioritized beloved Boston operators with deep local followings to create a vibrant, inclusive district that authentically connects to Allston-Brighton and the broader Boston community. In addition to Comfort Kitchen's Ama restaurant and Foxglove Terrace, the ERC is home to neighborhood favorites including Harvard's iconic COOP bookstore and apparel shop, Revival Café, Phin Coffee House and First Chapters daycare center. Two acres of activated publicly accessible open space, with the new Allstonway as its centerpiece. Opened in May, the Allstonway, designed by SCAPE, connects the neighborhood to the Charles River, bringing people of all ages together through public art, landscaping, walking paths, comfortable seating and year-round programming such as farmer's markets, concerts and outdoor fitness classes. Tishman Speyer is a leading owner, developer, operator and investment manager of first-class real estate in 33 key markets across the United States, Europe, Asia and Latin America. Our portfolio spans market rate and affordable residential communities, premier office properties and retail spaces, industrial facilities, and mixed-use campuses. We create state-of-the-art life science centers through our Breakthrough Properties joint venture, and foster innovation through our strategic proptech investments. With global vision, on-the-ground expertise and a personalized approach, we are unparalleled in our ability to foster innovation, quickly adapt to global and local trends and proactively anticipate our customers' evolving needs. By focusing on health and wellness, enlightened placemaking and customer-focused initiatives such as our tenant amenities platform, ZO, and our flexible space and co-working brand, Studio, we tend not just to our physical buildings, but to the people who inhabit them on a daily basis. Since our inception in 1978, Tishman Speyer has acquired, developed, and operated 531 properties, totaling 221 million square feet, with a combined value of approximately $130 billion (U.S.). Our current portfolio includes such iconic assets as Rockefeller Center in New York City, The Springs in Shanghai, TaunusTurm in Frankfurt and the Mission Rock neighborhood currently being realized in San Francisco.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
We're working on gathering enough insights on this company, check back soon!
Industries
Company Size
51-200
Company Stage
Debt Financing
Total Funding
$41.8M
Headquarters
Los Angeles, CA
Founded
2019
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs